当前位置:首页 - 行情中心 - 科兴制药(688136) - 财务分析

科兴制药

(688136)

  

流通市值:52.29亿  总市值:52.29亿
流通股本:2.01亿   总股本:2.01亿

科兴制药(688136)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-0.19亿元,每股收益-0.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益172865.00万元,未分配利润25276.65万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产349043.80万元,负债176178.80万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入280,525,124.961,534,028,363.151,147,639,140.97700,464,766.25
营业总成本300,163,833.041,479,489,096.161,070,420,698.89653,551,426.35
其他经营收益
营业利润-25,691,090.37168,110,667.57117,673,761.9186,211,621.55
利润总额-25,834,096.17165,699,363.49115,338,711.4684,128,950.2
净利润-18,553,838.47152,744,259.08109,102,136.3478,962,472.06
每股收益
其他综合收益263,706.13-180,713.14-80,087.15-25,544.5
综合收益总额-18,290,132.34152,563,545.94109,022,049.1978,936,927.56
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,553,201,910.631,607,355,795.911,550,078,576.411,432,193,326.28
非流动资产:
非流动资产合计1,937,236,091.41,926,199,354.361,861,242,018.721,886,100,348.92
资产总计3,490,438,002.033,533,555,150.273,411,320,595.133,318,293,675.2
流动负债:
流动负债合计1,037,150,463.11,021,257,003.81,032,648,614.83913,266,791.04
非流动负债:
非流动负债合计724,637,559.1759,791,779.87662,546,077.37719,913,485.41
负债合计1,761,788,022.21,781,048,783.671,695,194,692.21,633,180,276.45
所有者权益(或股东权益):
归属于母公司股东权益合计1,727,752,628.811,750,991,742.171,713,948,639.841,682,157,277.01
股东权益合计1,728,649,979.831,752,506,366.61,716,125,902.931,685,113,398.75
负债和股东权益合计3,490,438,002.033,533,555,150.273,411,320,595.133,318,293,675.2
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计346,684,8141,398,636,678.96929,454,734.91606,518,800.32
经营活动现金流出小计339,767,384.491,312,607,793.17936,712,263.1576,720,717.59
经营活动产生的现金流量净额6,917,429.5186,028,885.79-7,257,528.1929,798,082.73
投资活动产生的现金流量:
投资活动现金流入小计287,967,761.581,794,474,172.221,362,838,531.45825,010,393.29
投资活动现金流出小计326,322,293.841,858,236,114.821,518,701,955.761,026,375,715.58
投资活动产生的现金流量净额-38,354,532.26-63,761,942.6-155,863,424.31-201,365,322.29
筹资活动产生的现金流量:
筹资活动现金流入小计143,900,000935,799,708.76729,011,188.76440,049,226.94
筹资活动现金流出小计163,060,610.33862,485,611.85628,626,263.6376,233,605.33
筹资活动产生的现金流量净额-19,160,610.3373,314,096.91100,384,925.1663,815,621.61
汇率变动对现金及现金等价物的影响-2,536,495.53-210,761.57786,051.791,033,973.31
现金及现金等价物净增加额-53,134,208.6195,370,278.53-61,949,975.55-106,717,644.64
期末现金及现金等价物余额595,188,012.51648,322,221.12491,001,967.04446,234,297.95
补充资料:
现金及现金等价物的净增加额-95,370,278.53--106,717,644.64
最新报告期:2026-05-08
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信证券陈竹,王凯旋0.620.841.122026-05-08
东吴证券朱国广0.921.091.352026-04-29
平安证券叶寅,曹艳凯0.921.25--2026-04-13
财通证券华挺0.911.21--2026-04-02
TOP↑